Part One – Importance of Engaging Patient Organizations

Market development for products within the rare disease therapeutic area is both rewarding and challenging. By its very definition, the rareness of a disease means there is often very little information or historical data available about it. This creates challenges for marketers and often adds more time and resources to the endeavor. In my 30-plus

Read More